This course has expired. View available courses.
Rheumatology
Considering Biological and Biosimilar Medicines to Treat Rheumatic Diseases – Making the Right Call – The Australian Pharmacy Council
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterised by joint swelling, joint tenderness and destruction of synovial joints. The primary goal in treating patients with RA is to maximise long-term quality of life. In recent years, treat-to-target recommendations have been formulated for the management of RA. These targets include either remission (the absence of symptoms or signs of inflammatory disease activity) or low-level disease activity.
DURATION
1 hr
PROFESSION
Pharmacy
# OF CREDITS
2
ACCREDITATION
EXPIRY DATE
2020-04-03
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterised by joint swelling, joint tenderness and destruction of synovial joints. The primary goal in treating patients with RA is to maximise long-term quality of life. In recent years, treat-to-target recommendations have been formulated for the management of RA. These targets include either remission (the absence of symptoms or signs of inflammatory disease activity) or low-level disease activity.
Faculty
Adjunct Associate Professor Deborah Rigby
BPharm, GradDipClinPharm, AdvDipNutrPharm, AdvPracPharm,
AACPA, FPS, FASCP, FACP, FSHP, FAICD
Adjunct Associate Professor, University of Queensland,
Adjunct Associate Professor, Queensland University of Technology
Brisbane, Queensland